Managing and analyzing data for predicting disease progression in patients.
NAPS2 Data Management and Statistics Core
['FUNDING_OTHER'] · WASHINGTON UNIVERSITY · NIH-10866389
This study is looking at how certain sleep disorders, like REM sleep behavior disorder, affect people with specific brain conditions, and it's designed to help patients understand their illness better and predict how it might change over time.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10866389 on ClinicalTrials.gov |
What this research studies
The NAPS2 Data Management and Statistics Core focuses on collecting and analyzing data related to the progression of synucleinopathies, particularly in patients with REM sleep behavior disorder. This core collaborates with various research teams to ensure high-quality data collection and analysis, employing advanced statistical methods and machine learning techniques. By standardizing data management practices, the core aims to enhance the reliability of findings related to disease markers and their progression. Patients may benefit from improved understanding and prediction of their disease trajectory through this comprehensive data approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with REM sleep behavior disorder or related synucleinopathies.
Not a fit: Patients without a diagnosis of REM sleep behavior disorder or those with unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better predictions of disease progression for patients with synucleinopathies.
How similar studies have performed: Previous research has shown success in using centralized data management and advanced statistical techniques to improve understanding of disease progression in similar conditions.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: XIONG, CHENGJIE — WASHINGTON UNIVERSITY
- Study coordinator: XIONG, CHENGJIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.